Jiangsu Carefree Pharmaceutical Co., Ltd.   Report issue

For profit Phase 3
Founded: Nanjing China (2006)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2013
NCT01637675
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (3)

danshen (1 trial)

glucose (1 trial)

sildenafil (viagra) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiovascular Diseases (Phase 3)

Hypertension (Phase 3)

Hypertension, Pulmonary (Phase 3)

Lung Diseases (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 3